| | CASMASCI | progen | BOC | 進口現貨產品 | 胎牛血清 | 細胞培養 | 提取試劑 | 轉染試劑 | 常規生化試劑 | ELISA試劑盒 | 抗體 | 細胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產品名稱:Acipimox
產品貨號:LKT A0833
產品規格:1g 5g 10g
Acipimox
Description
Acipimox inhibits lipolysis in peripheral tissues and induces large reduction in circulating serum-free fatty acids. The mechanism of triglyceride lowering appears to be an increase of VLDL-Tg clearance.
Specifications
Cas No. 51037-30-0
Product ID A0833
Product Name Acipimox
Chemical Name 5-Methylpyrazinecarboxylic acid 4-oxide
Synonym Neotigason; Soriatane
Formula Wt. 154.12
Melting Point 177oC-180oC
Purity ≥98%
Solubility Water 20 mg/mL
Store Temp Ambient
References Nuutinen, J. Minn, H., Bergmand, J. et al Br. J. Cancer 80:513-518 (1999). Hannah, J.S., Bodkin, NL., Paidi,, MS., et al. Acta Diabetol. 32:279-283 (1995).